Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
Clinical trial NCT03352531 · COMPLETED
Trial details
- NCT number
- NCT03352531
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2020-11-30
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.